CALGB 30601: A phase II study of dasatinib (D) in patients (pts) with previously treated malignant mesothelioma (MM)
- Citation:
- J Clin Oncol vol 28 (15s) abstr 7037
- Meeting Instance:
- ASCO 2010
- Year:
- 2010
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 720
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- A. Z. Dudek H. L. Kindler G. A. Otterson H. Pang R. A. Kratzke E. E. Vokes
- Networks:
- Study
- CALGB-30601
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: